Pharmacy

The FDA has approved Rinvoq, a once-daily oral pill for the treatment of moderate to severe rheumatoid arthritis. 

Teva Pharmaceuticals has launched its generic version of Mylan's EpiPen Jr., the lifesaving allergy treatment for young children.

American Regent recently hiked the price of an essential mineral used by hospitals to provide nutrients intravenously by 1,300 percent, according to STAT.

Six drugs or medical devices approved by the FDA since Aug. 2:

The FDA has approved Inrebic for the treatment of adult patients with certain types of myelofibrosis, a rare bone marrow disorder. 

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

Roche has priced its cancer treatment Rozlytrek at $17,050 per month, about half the cost of a similar drug sold by Eli Lilly and Bayer, according to STAT.

An unnamed manager at Novartis sold $946,000 worth of company shares less than three weeks before a scandal involving manipulated data became public, according to Bloomberg. 

Between 2011 and 2017, Medicare could have saved $17.7 billion if generic versions of older medicines were prescribed instead of updated brand-name drugs launched by drugmakers to replace their older off-patent pills, according to a new study published in the…

The FDA has approved Rozlytrek, Roche's personalized cancer treatment that targets tumors with a specific genetic mutation.